VERSANIS BIO
Versanis Bio discovers and develops medicines that address medical conditions prevalent in older adults. Versanis Bio is advancing Bimagrumab, a human monoclonal antibody to the activin type II receptors that block the binding of ligands including activin A and myostatin. Bimagrumab has been studied by Novartis in more than a dozen controlled clinical trials that enrolled more than 1,500 people. Across key studies, Bimagrumab treatment consistently and potently induced significant loss of fat mass without loss of lean mass, and additionally improved HbA1c and other cardiometabolic parameters.
VERSANIS BIO
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2021-01-01
Address:
Oakland, California, United States
Country:
United States
Website Url:
http://www.versanisbio.com
Total Employee:
11+
Status:
Active
Contact:
(617) 315-4410
Total Funding:
70 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon WordPress LetsEncrypt SSL By Default Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Board_member
2021-08-01
Board_member
2021-09-01
Current Employees Featured
Lloyd Klickstein Chief Scientific Officer @ Versanis Bio
Chief Scientific Officer
2022-04-01
Mark Pruzanski Chairman and Chief Executive Officer @ Versanis Bio
Chairman and Chief Executive Officer
2022-04-01
Mark Fishman Founder @ Versanis Bio
Founder
Joe Jimenez Founder @ Versanis Bio
Founder
Founder
Investors List
Aditum Bio
Aditum Bio investment in Series A - Versanis Bio
TCG Crossover
TCG Crossover investment in Series A - Versanis Bio
Medicxi
Medicxi investment in Series A - Versanis Bio
Atlas Venture
Atlas Venture investment in Series A - Versanis Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-20 | Versanis Bio appoints Mark Pruzanski as CEO |
Official Site Inspections
http://www.versanisbio.com Semrush global rank: 6.95 M Semrush visits lastest month: 968
- Host name: ec2-18-188-128-145.us-east-2.compute.amazonaws.com
- IP address: 18.188.128.145
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Versanis Bio"
Versanis | Subsidiaries | Eli Lilly and Company
Overview. We can imagine a healthier future for people living with obesity. We’re closer than ever before. Combining Versanis’ deep understanding of activin biology with Lilly’s expertise in …See details»
Versanis Bio - Crunchbase Company Profile & Funding
Organization. Versanis Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Lilly to Acquire Versanis to Improve Patient Outcomes in ...
Jul 14, 2023 The company's lead asset, bimagrumab, is being advanced in the BELIEVE Phase 2b study as a novel treatment to help adults achieve and maintain both fat loss and a healthy …See details»
Lilly Completes Acquisition of Versanis Bio
INDIANAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Versanis Bio. The acquisition …See details»
Versanis Bio 2025 Company Profile: Valuation, …
Versanis Bio General Information Description. Developer of medicines designed to address medical conditions prevalent in older adults. The company offers …See details»
Versanis Bio, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Versanis Bio, Inc. of Oakland, CA. Get the latest business insights from Dun & Bradstreet.See details»
Versanis Bio - LifeScienceHistory.com
Www.versanisbio.com. 31 Hudson Yards, 11th Floor. New York, NY 10001. Company Info Year Established 2021 Ticker LLY Exchange NYSE. Contacts Mark Pruzanski Chair & CEO Lloyd …See details»
Versanis Bio - Craft
Versanis Bio is a biotech company developing bimagrumab for the treatment of obesity in adults. It provide bimagrumab, a human monoclonal antibody to the activin type II receptors that block …See details»
Eli Lilly acquires Versanis Bio - 2023-07-14 - Crunchbase
Jul 14, 2023 Acquiring Organization: Eli Lilly Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products. Announced Date Jul 14, 2023; ...See details»
Versanis Bio Announces Leadership and Board Appointments as …
Jul 20, 2022 Most notably, he founded Intercept Pharmaceuticals and was the company's CEO until 2021, having led its evolution from a drug discovery stage to a global development and …See details»
Lilly to Acquire Versanis to Improve Patient Outcomes …
Jul 14, 2023 For more information, please visit www.versanisbio.com. About Lilly . Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been ...See details»
Versanis Bio - VentureRadar
"Versanis Bio was established to develop first-in-class medicines that address medical conditions prevalent in older adults. Bimagrumab is the lead Versanis Bio program, with a goal of helping …See details»
Lilly Completes Acquisition of Versanis Bio - PR Newswire
INDIANAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Versanis Bio.The acquisition …See details»
Versanis Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
The remarkable success of Operation Warp Speed for the rapid development of COVID-19 vaccines, COVID-19 therapeutics, and of oncology drug development programs over the past …See details»
Versanis Bio - Overview, News & Similar companies - ZoomInfo
Aug 13, 2023 Popular Searches Versanis Bio Versanis Bio Inc Versanis Versanisbio SIC Code 28,283 NAICS Code 32,325 Show more. Versanis Bio Org Chart. Debbie Dolan. Director, …See details»
Versanis Bio Announces Leadership and Board ... - Markets Insider
Jul 20, 2022 Most notably, he founded Intercept Pharmaceuticals and was the company's CEO until 2021, having led its evolution from a drug discovery stage to a global development and …See details»
Versanis Bio, Inc. (Versanis Bio, Inc.) - 药物管线_专利_临床试验_投 …
The remarkable success of Operation Warp Speed for the rapid development of COVID-19 vaccines, COVID-19 therapeutics, and of oncology drug development programs over the past …See details»
Lilly to Acquire Versanis to Improve Patient Outcomes in ...
Jul 14, 2023 For more information, please visit www.versanisbio.com. About Lilly . Lilly unites caring with discovery to create medicines that make life better for people around the world. …See details»
Versanis Bio Announces Leadership and Board Appointments
Jul 20, 2022 Versanis Bio, a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, today announced three organizational appointments.Versanis …See details»
Versanis Bio Announces $70 Million Series A Financing to Advance ...
Aug 31, 2021 Media For inquiries, please contact: Kevin Nguyen Versanis Bio (617) 315-4410 info@versanisbio.com. Company. About Business Wire Careers Media Center. Services.See details»